Molecular epidemiology of clinical isolates of AmpC producing Klebsiella pneumoniae

Indian Journal of Medical Microbiology

Volumn 24, Issue 3, 2006, Pages 177-181

  Manchanda, V ^a   Singh, N ^a   Shamweel, A ^b   Eideh, H ^b   Thukral, S ^b  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b UCMS AND GTB HOSPITAL   (India)

Author keywords

AmpC; ESBL; Klebsiella pneumoniae; Protein fingerprinting; Ribotyping; SDS PAGE

Indexed keywords

BETA LACTAMASE AMPC; CEFOTETAN; CEFOXITIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; COMMUNITY; CONTROLLED STUDY; FEMALE; HOSPITAL; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NEWBORN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREVALENCE; RIBOTYPING; WHOLE CELL;

EID: 33748133776     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990;34:2200-9.
2. Gazouli M, Kaufmann ME, Tzelepi E, Dimopoulou H, Paniara O, Tzouvelekis LS. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997;35:508-10.
3. M'Zali FH, Heritage J, Gascoyne-Binzi DM, Denton M, Todd NJ, Hawkey PM. Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital. J Antimicrob Chemother 1997;40:823-31.
4. Horii T, Arakawa Y, Ohta M, Ichiyama S, Wacharotayankun R, Kato N. Plasmid-mediated AmpC-type beta-lactamase isolated from Klebsiella pneumoniae confers resistance to broad-spectrum beta-lactams, including moxalactam. Antimicrob Agents Chemother 1993;37:984-90.
5. Philippon A, Arlet G, Jacoby GA. Plasmid-Determined AmpC-Type beta-lactamases. Antimicrobial Agents Chemother 2002;46:1-11.
6. Barnaud G, Labia R, Raskine L, Sanson-Le Pors MJ, Philippon A, Arlet G. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate. FEMS Microbiol Lett 2001;195:185-90.
7. Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003;51:415-8.
8. Subha A, Devi VR, Ananthan S. AmpC beta-lactamase producing multidrug resistant strains of Klebsiella spp. & Escherichia coli isolated from children under five in Chennai. Indian J Med Res 2003;117:13-8.
9. Shahid M, Malik A, Sheeba. Multidrug-resistant Pseudomonas aeruginosa strains producing R-plasmids and AmpC beta-lactamases isolated from hospitalised burn patients in a tertiary care hospital of North India. FEMS Microbiol Lett 2003;228:181-6.
10. Ratna AK, Menon I, Kapur I, Kulkarni R. Occurrence & detection of AmpC beta-lactamases at a referral hospital in Karnataka. Indian J Med Res 2003;118:29-32.
11. Aubert D, Girlich D, Naas T, Nagarajan S, Nordmann P. Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 2004;48:3284-90.
12. th ed. (Churchill Livingstone: Edinburgh, UK) 1996: 361-84.
13. th informational supplement. National Committee for Clinical Laboratory Standards: Wayne, Pennsylvania; 2000. M100-S10.
14. Costas M, Holmes B, Sloss LL. Comparison of SDS-PAGE protein patterns with other typing methods for investigating the epidemiology of 'Klebsiella aerogenes'. Epidemiol Infect 1990;104:455-65.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
16. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM, van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
17. Haertl R, Barten R, Bandlow G. Epidemiological fingerprinting of Klebsiella pneumoniae by small-fragment-restriction-endonuclease-analysis (SF-REA). Scand J Infect Dis 1991;23:737-43.
18. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: An application of Simpson's index of diversity. J Clin Microbiol 1988;26:2465-6.
19. Rice LB. Successful interventions for gram-negative resistance to extended spectrum beta-lactamase antibiotics. Pharmacotherapy 1999;19:120S-8S.
20. Pena C, Pujol M, Ricart A, Ardanuy C, Ayats J, Linares J, et al. Risk factors for fecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in intensive care unit. J Hosp Infect 1997;35:9-16.
21. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162-71.
22. Arlet G, Rouveau M, Casin I, Bouvet PJ, Lagrange PH, Philippon A. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol 1994;32:2553-8.